EXL Announce Transformational H1 Results
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Elixinol Wellness Ltd has reported significantly improved operating results for the first half of the fiscal year, highlighting a notable increase in revenue and a reduction in operating expenses. The company achieved a substantial improvement in gross margin and a decrease in adjusted EBITDA loss compared to the previous year. Additionally, Elixinol has executed an agreement to divest its US business, allowing for a more focused approach on its Australian operations. Looking ahead, the company aims to sustain its operational improvements and explore new growth opportunities in the second half of the fiscal year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Elixinol Wellness
- EXL Investor Presentation
- The Healthy Chef expands into Priceline
- Repositioned for Sustainable Growth and Margin Expansion
- FY25 Results Investor Presentation
- FY25 Appendix 4E and Annual Report
Later from Elixinol Wellness
- EXL Completion of Divestment of United States Business
- EXL to Acquire Vitable Presentation
- Elixinol Hemp Sales and Gross Profit Accelerate
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Elixinol Wellness into a list and get an email when it puts out news.
Follow Elixinol Wellness